Overview

Update
Total Equity Funding
$29.05M in 5 Rounds from 7 Investors
Most Recent Funding
$1.5M Grant on September 26, 2016
Headquarters:
San Carlos, CA
Description:
Cellerant Therapeutics is a biotechnology company offering products for the regulation of the hematopoietic system.
Founders:
Categories:
Therapeutics, Biotechnology, Clinical Trials
Website:
http://www.cellerant.com
Social:

Company Details

Update

Cellerant Therapeutics is a biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. The company focuses on curative therapies for seriously ill patients.

Cellerant is developing a novel, cell-based medicine (Myeloid Progenitors / CLT-008) as a treatment for chemotherapy- and radiation-induced neutropenia as well as for Acute Radiation Syndrome. And we are applying our expertise in hematopoietic ontogeny to identify novel drug targets and therapeutic antibodies aimed at cancer stem cells.

Funding Rounds (11) - $99.77M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2016$1.5M / Grant0
Apr, 2016$2.03M / Debt Financing0
Sep, 2014$47.5M / Grant0
Jan, 2014$2.19M / Debt Financing0
Sep, 2012$2.09M / Venture2
Sep, 2011$16.7M / Grant0
Aug, 2011$800k / Debt Financing0
Dec, 2010$2.02M / Venture0
Feb, 2010$4.54M / Venture0
Apr, 2007$4.4M / Series B2
May, 2005$16M / Series B5

Current Team (9)

Update

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • HQ

    1561 Industrial Road

    San Carlos, CA 94070

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos